A preventive treatment for dementia may proceed to clinical trials after successful animal testing say researchers. The research is looking to develop effective immunotherapy via a new vaccine to remove 'brain plaque' and tau protein aggregates linked to Alzheimer's disease. Recent success in bigenic mice models supports progression to human trials in years to come the research added. The study published in the journal Alzheimer's Research & Therapy paves the way for more work in 2020 with medical researchers at the Institute for Molecular Medicine and University of California Irvine (UCI) working with a successful vaccine formulated on adjuvant developed